Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NANOPARTICULATE FORMULATION FOR CANCER DISEASE TREATMENT
Document Type and Number:
WIPO Patent Application WO/2017/170564
Kind Code:
A1
Abstract:
[Problem] To provide a novel DDS having SN-38 as the medicinal component. [Solution] An excellent SN-38 ester derivative with cancer cell proliferation inhibitory activity is provided which is effective in nanodrug production.

Inventors:
KASAI HITOSHI (JP)
KOSEKI YOSHITAKA (JP)
Application Number:
PCT/JP2017/012669
Publication Date:
October 05, 2017
Filing Date:
March 28, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TOHOKU (JP)
International Classes:
C07J43/00; A61K9/16; A61K31/4745; A61K31/58; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P11/04; A61P13/08; A61P13/10; A61P15/00; A61P35/00; C07D491/22
Domestic Patent References:
WO2005118612A12005-12-15
WO2013188727A22013-12-19
Foreign References:
CN101967173A2011-02-09
CN105315294A2016-02-10
US20140135356A12014-05-15
US20080045559A12008-02-21
Other References:
WANG, HANGXIANG ET AL.: "Structure‐Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 53, no. 43, 2014, pages 11532 - 11537, XP055601540$
Attorney, Agent or Firm:
SHA Takuho (JP)
Download PDF: